Structure | Catalog # | Chemical Name | CAS | MF | MW | |
---|---|---|---|---|---|---|
BL10739 | CWHM-1552 | 2368253-58-9 | C22H27F2N3O | 387.4661 | VIEW DETAILS > | |
BL10753 | CYH33 methanesulfonate | 1494684-33-1 | C25H33F3N8O8S2 | 694.7035 | VIEW DETAILS > | |
BL20556 | CIPROFLOXACIN:HCL 100 UG/ML IN METHANOL (2,3,CARBOXYL-13C3, 99%; QUINOLINE-15N, 98%) | 2483830-12-0 | C17H19ClFN3O3 | 371.7738 | VIEW DETAILS > | |
BM03727 | CLinDMA | 908860-82-2 | C54H97NO3 | 808.3529 | VIEW DETAILS > | |
BM03749 | Crizanlizumab | 1690318-25-2 | VIEW DETAILS > | |||
BM03765 | CH7233163 | 2923365-71-1 | C31H34F3N9O3S | 669.7204 | VIEW DETAILS > | |
BM05465 | C-Type Natriuretic Peptide (CNP) (1-22), human TFA | 1966153-17-2 | C95H158F3N27O30S3 | 2311.6241 | VIEW DETAILS > | |
BM13495 | CDK4/6-IN-15 | 2078047-99-9 | C21H27FN8S | 442.5561 | VIEW DETAILS > | |
BM14453 | CJJ300 | 1807631-83-9 | C30H33N3 | 435.6031 | VIEW DETAILS > | |
BM26131 | CKLF1-C27 | 891861-48-6 | VIEW DETAILS > |